Open AccessConsumer satisfaction with National Alliance on Mental Illness written medicine information
Author(s) -
Michelle Colvard,
Marie-Thérèse Jackson,
Rosana Rosseto de Oliveira,
Karin Scholtes,
Steven Burghart,
Christina Gutierrez,
Troy Moore,
Shan N. Saldaña,
Amy VandenBerg
Publication year - 2017
Publication title -
the mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.2017.03.074
Subject(s) - alliance , mental illness , psychology , psychiatry , mental health , political science , law
Written medicine information (WMI) is a collection of facts for a specific medication, and it helps facilitate patient understanding of medication therapy. The primary objective of this study was to assess consumer satisfaction with National Alliance on Mental Illness (NAMI) WMI. A secondary objective was to assess health care professional satisfaction. Methods: National Alliance on Mental Illness WMI and surveys were offered to consumers, health care professionals, and trainees at 3 treatment centers with psychiatric services. All adults who received medication counseling were eligible for inclusion. Survey responses were evaluated using descriptive statistics. Results: Most consumers (82.4%) and providers (74.5%) reported overall satisfaction with NAMI WMI. Consumers were least satisfied with information on how to manage unwanted effects, drug-drug interactions, and readability (9.5%, 14.9%, 41.9% dissatisfaction). Discussion: Evaluation and feedback from consumers and health care professionals may influence decisions to refine NAMI WMI to meet consumer needs.